| Bassil I. Dahiyat | President, Chief Executive Officer and Director | FY2025 | |
| John R. Desjarlais, Ph.D. | Chief Scientific Officer | FY2025 | |
| Bart Jan Cornelissen | Chief Financial Officer | FY2025 | |
| Celia E. Eckert | General Counsel | FY2025 | |
| Nancy K. Valente, M.D. | Former Chief Development Officer | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.